Alzheimer’s disease
Explore selected studies in early Alzheimer’s disease, prevention in people without cognitive impairment, and Alzheimer’s-related psychosis. The linked record defines who each study includes.
Explore researchLoading research and source information…
Evidence, with context
Follow selected clinical trials: what was studied, whether enrollment is open, and where to read the original records and posted results.
Browse selected FDA labels, registry studies and safety sources with indication-specific context.
Explore peptide researchExplore selected studies in early Alzheimer’s disease, prevention in people without cognitive impairment, and Alzheimer’s-related psychosis. The linked record defines who each study includes.
Explore researchExplore selected Crohn’s disease studies. Each registry record describes its population and eligibility.
Explore researchExplore selected studies in fatty liver disease and steatohepatitis. The study record identifies the specific diagnosis and population; these terms are not interchangeable for every patient.
Explore researchExplore selected multiple sclerosis studies. Trial populations and disease subtypes vary.
Explore researchExplore selected studies involving obesity. Each trial defines its own participants, intervention and outcomes.
Explore researchExplore selected studies in early and moderate Parkinson’s disease, including drug and gene-therapy research. Eligibility, disease stage and study design differ between trials.
Explore researchExplore selected sleep apnea studies. The registry record specifies the type of sleep apnea and who may be eligible.
Explore researchExplore selected type 2 diabetes studies of blood sugar control and cardiovascular risk. Some studies require specific background treatment or other health conditions.
Explore researchResults, corrections and discontinued programs share the same dated feed.
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.
Initial coverage is limited to the conditions and sources listed here, with United States regulatory context. The study listings are a selection, focused on drug and biological treatments; device, behavioral and other studies may be missing. Condition pages are not treatment rankings. Research updates do not subscribe you to, or trigger, safety alerts.
Trial registration is supplied by the sponsor or responsible party. A completed trial, a higher phase or a promising announcement does not establish clinical benefit.
The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.